Related Experiment Videos
Glycogen storage disease: recommendations for treatment
J Fernandes1, J V Leonard, S W Moses
1Department of Paediatrics, University Hospital, Groningen, The Netherlands.
European Journal of Pediatrics
|April 1, 1988
Summary
Consensus on treating glycogen storage diseases was established. Recommendations cover glucose-6-phosphatase, translocase, debranching enzyme, and phosphorylase deficiencies in patients.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Pediatric Medicine
Background:
- Glycogen storage diseases (GSDs) are a group of inherited metabolic disorders.
- Effective management strategies for GSDs are crucial for patient outcomes.
- Previous treatment guidelines lacked comprehensive consensus.
Purpose of the Study:
- To establish consensus on the treatment of specific glycogen storage diseases.
- To provide unified recommendations for managing GSD patients.
- To address deficiencies in glucose-6-phosphatase, glucose-6-phosphate translocase, debranching enzyme, liver phosphorylase, and phosphorylase-b-kinase.
Main Methods:
- A workshop was convened under the European Communities' Concerted Action on Inborn Errors of Metabolism.
- Expert consensus was developed through collaborative discussion.
- Key treatment aspects for specific GSD enzyme deficiencies were reviewed.
Main Results:
- Consensus was achieved on the primary treatment issues for five GSD types.
- Specific recommendations were formulated for managing deficiencies in key metabolic enzymes.
- The workshop facilitated agreement on critical management pathways.
Conclusions:
- The workshop successfully generated consensus on GSD treatment.
- These recommendations provide a unified approach to managing patients with specific GSDs.
- The findings support improved care for individuals with these metabolic disorders.